Am. J. Respir. Crit. Care Med., Volume 158, Number 5, November 1998, S201-S206

Airway Smooth Muscle as a Target of Glucocorticoid Action in the Treatment of Asthma

STUART J. HIRST and TAK H. LEE

Department of Allergy and Respiratory Medicine, UMDS, Thomas Guy House, Guy's Hospital, London, United Kingdom

Glucocorticoids are highly effective in the control of asthma and suppression of airway inflammation. The cellular and molecular mechanisms involved in the anti-inflammatory actions of glucocorticoids are becoming clearer. Although it is apparent that glucocorticoids have effects on many aspects of inflammation, it is not certain which actions on which cell types are the most critical in controlling asthma. Airway smooth muscle cells represent a significant proportion of all cells present in the airways and might therefore be expected to be a prominent cellular target for inhaled steroids. Despite this, little is known of the action of glucocorticoids on airway smooth muscle. It is becoming clear that in addition to its contractile properties, airway smooth muscle can potentially contribute to the pathogenesis of asthma by increased proliferation and by expression and secretion of pro-inflammatory cytokines and mediators, which in turn may lead to the activation and recruitment of key inflammatory cells in the airways. This review examines the action of glucocorticoids on some of the diverse functions of airway smooth muscle that are implicated in remodeling of the airways in asthma. Glucocorticoids either directly or indirectly modulate contraction of airway smooth muscle by suppressing agonist-induced increases in intracellular calcium levels or by downregulating or uncoupling receptors linked to contraction (e.g., muscarinic M₂ or M₃, histamine H₁ receptors). In addition, glucocorticoids may augment relaxation of airway smooth muscle by increasing activation of either cyclic AMP-dependent (e.g., increased expression of ₂-adrenoceptors, reduced homologous desensitization of ₂-adrenoceptors) or AMP-independent mechanisms (e.g., increased Na⁺/K⁺ electrogenic pump activity). In addition to their effects on contraction, glucocorticoids are also effective antiproliferative agents in airway smooth muscle, but under some circumstances may also contribute to proliferation by inhibiting the antiproliferative effect of high concentrations of tumor necrosis factor alpha in these cells. Glucocorticoids also suppress induction of cyclooxygenase-2 in human airway smooth muscle cells and the subsequent synthesis and release of arachidonic acid metabolites, particularly prostaglandin E₂. The potential of airway smooth muscle to recruit and activate pro-inflammatory cells such as the eosinophil may also be reduced by glucocorticoids, as they are effective in preventing the release of several cytokines (e.g., RANTES, interleukin-8, and granulocyte macrophage colony-stimulating factor). The possibility exists that as we begin to understand and speculate more about the likely role of airway smooth muscle in the pathogenesis of asthma, it may be necessary to reconsider airway smooth muscle as an important cellular target for the action of glucocorticoids in the treatment of asthma. Hirst SJ, Lee TH. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma.

This article has been cited by other articles:

				O. J. Lakser, M. L. Dowell, F. L. Hoyte, B. Chen, T. L. Lavoie, C. Ferreira, L. H. Pinto, N. O. Dulin, P. Kogut, J. Churchill, et al. Steroids augment relengthening of contracted airway smooth muscle: potential additional mechanism of benefit in asthma Eur. Respir. J., November 1, 2008; 32(5): 1224 - 1230. [Abstract] [Full Text] [PDF]

				H. Sun, E. Sheveleva, B. Xu, H. Inoue, T. G. Bowden, and Q. M. Chen Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-{beta} Am J Physiol Cell Physiol, October 1, 2008; 295(4): C915 - C922. [Abstract] [Full Text] [PDF]

				O. Tliba, G. Damera, A. Banerjee, S. Gu, H. Baidouri, S. Keslacy, and Y. Amrani Cytokines Induce an Early Steroid Resistance in Airway Smooth Muscle Cells: Novel Role of Interferon Regulatory Factor-1 Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 463 - 472. [Abstract] [Full Text] [PDF]

				O. Tliba, Y. Amrani, and R. A. Panettieri Jr Is Airway Smooth Muscle the "Missing Link" Modulating Airway Inflammation in Asthma? Chest, January 1, 2008; 133(1): 236 - 242. [Abstract] [Full Text] [PDF]

				O. Tliba and Y. Amrani Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112. [Abstract] [Full Text] [PDF]

				A. M. Goldsmith, M. B. Hershenson, M. P. Wolbert, and J. K. Bentley Regulation of airway smooth muscle {alpha}-actin expression by glucocorticoids Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L99 - L106. [Abstract] [Full Text] [PDF]

				A. M. Slats, J. K. Sont, R. H.C.J. van Klink, E. H.D. Bel, and P. J. Sterk Improvement in bronchodilation following deep inspiration after a course of high-dose oral prednisone in asthma. Chest, July 1, 2006; 130(1): 58 - 65. [Abstract] [Full Text] [PDF]

				A. Hichami, C. Morin, E. Rousseau, and N. A. Khan Diacylglycerol-Containing Docosahexaenoic Acid in Acyl Chain Modulates Airway Smooth Muscle Tone Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 378 - 386. [Abstract] [Full Text] [PDF]

				M. Roth, P. R.A. Johnson, P. Borger, M. P. Bihl, J. J. Rudiger, G. G. King, Q. Ge, K. Hostettler, J. K. Burgess, J. L. Black, et al. Dysfunctional Interaction of C/EBP{alpha} and the Glucocorticoid Receptor in Asthmatic Bronchial Smooth-Muscle Cells N. Engl. J. Med., August 5, 2004; 351(6): 560 - 574. [Abstract] [Full Text] [PDF]

				L. Benayoun, A. Druilhe, M.-C. Dombret, M. Aubier, and M. Pretolani Airway Structural Alterations Selectively Associated with Severe Asthma Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1360 - 1368. [Abstract] [Full Text] [PDF]

				L. Brichetto, M. Milanese, P. Song, M. Patrone, E. Crimi, K. Rehder, and V. Brusasco Beclomethasone rapidly ablates allergen-induced beta 2- adrenoceptor pathway dysfunction in human isolated bronchi Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L133 - L139. [Abstract] [Full Text] [PDF]

				J. J. RUDIGER, M. ROTH, M. P. BIHL, B. C. CORNELIUS, M. JOHNSON, R. ZIESCHE, and L.-H. BLOCK Interaction of C/EBP{alpha} and the glucocorticoid receptor in vivo and in nontransformed human cells FASEB J, February 1, 2002; 16(2): 177 - 184. [Abstract] [Full Text] [PDF]

				N. J. VANACKER, E. PALMANS, J. C. KIPS, and R. A. PAUWELS Fluticasone Inhibits But Does Not Reverse Allergen-Induced Structural Airway Changes Am. J. Respir. Crit. Care Med., March 1, 2001; 163(3): 674 - 679. [Abstract] [Full Text] [PDF]

				N. Lazzeri, M. G. Belvisi, H. J. Patel, M. H. Yacoub, K. Fan Chung, and J. A. Mitchell Effects of Prostaglandin E2 and cAMP Elevating Drugs on GM-CSF Release by Cultured Human Airway Smooth Muscle Cells . Relevance to Asthma Therapy Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 44 - 48. [Abstract] [Full Text]

				S. McKay, S. J. Hirst, M. B.-d. Haas, J. C. de Jongste, H. C. Hoogsteden, P. R. Saxena, and H. S. Sharma Tumor Necrosis Factor-alpha Enhances mRNA Expression and Secretion of Interleukin-6 in Cultured Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 103 - 111. [Abstract] [Full Text]